Trial site
Vanderbilt Medical Center
- 9running trials
- 6closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease3 trials
- Kidney cancer3 trials
- Colorectal cancer2 trials
- Head and neck cancer2 trials
- Mild cognitive impairment2 trials
- Pancreatic cancer2 trials
- Atrial fibrillation1 trial
- Autism1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- Liver and biliary tract cancer1 trial
- Migraine1 trial
- and 3 more
- Phase
- Phase 13 trials
- Phase 23 trials
- Phase 33 trials
- Phase 1/21 trial
- Phase 41 trial
- Status
- Completed5 trials
- Active, not recruiting4 trials
- Recruiting4 trials
- Enrolling by invitation1 trial
- Terminated1 trial
- Lead sponsor
- Incyte Corporation3 trials
- Novo Nordisk A/S2 trials
- Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2 trials
- Vanderbilt University Medical Center2 trials
- Artios Pharma Ltd1 trial
- and 5 more
Running trials
Enrolling by invitation
Recruiting
Recruiting
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Recruiting
Active, not recruiting
Active, not recruiting
Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Kidney cancer1 recruiting
- Migraine1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD
Completed
Terminated
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026